Patient-reported outcomes and daily activity assessed with a digital wearable device in patients with paroxysmal nocturnal hemoglobinuria treated with ravulizumab: REVEAL, a prospective, observational study
- Elizabeth A. Griffiths
- , Jae S. Min
- , Wei Nchih Lee
- , Jeffrey C. Yu
- , Yogesh Patel
- , Karl Johan Myren
- , David Dingli
- Evidation Health
- AstraZeneca
- Inc.
- Mayo Clinic Rochester, MN
Research output: Contribution to journal › Article › peer-review
5
Scopus
citations